top of page
Between invention and impact: what INPI and GII data reveal about the urgency of health innovation in Brazil
In recent years, Brazil has faced a persistent paradox: it produces ever-increasing amounts of science, but continues to transform little...
Oct 86 min read
FDA Approved: New Long-Acting PrEP Regimen and Its Implications
In June 2025, the US Food and Drug Administration approved a new HIV pre-exposure prophylaxis (PrEP) regimen: the long-acting injectable...
Jun 2330 min read
Building Global Power: A National Strategy for Deeptech Health Startups in Brazil
The emergence of cutting-edge technologies, known as deeptechs, marks a new phase in global innovation. These technologies, which emerge...
Jun 633 min read
The Importance of Regulatory Agencies in Health Innovation and Pharmaceutical Regulation: FDA, EMA, and ANVISA in Perspective
Health innovation and the remarkable growth of the pharmaceutical sector—with a projected global revenue of USD 1.155 trillion in...
Nov 1, 20244 min read
bottom of page